A novel NMDA receptor test model based on hiPSC-derived neural cells

Disse P, Aymanns I, Ritter N, Peischard S, Korn L, Wiendl H, Pawlowski M, Kovac S, Meuth SG, Budde T, Strutz-Seebohm N, Wünsch B, Seebohm G

Forschungsartikel (Zeitschrift) | Peer reviewed

Zusammenfassung

N-Methyl-D-aspartate receptors (NMDARs) are central for learning and information processing in the brain. Dysfunction of NMDARs can play a key role in the pathogenesis of neurodegeneration and drug addiction. The development of selective NMDAR modulators represents a promising strategy to target these diseases. Among such modulating compounds are ifenprodil and its 3-benzazepine derivatives. Classically, the effects of these NMDAR modulators have been tested by techniques like two-electrode voltage clamp (TEVC), patch clamp, or fluorescence-based assays. However, testing their functional effects in complex human systems requires more advanced approaches. Here, we established a human induced pluripotent stem cell-derived (hiPSC-derived) neural cell system and proved its eligibility as a test system for investigating NMDAR modulators and pharmaceutical effects on human neurons.

Details zur Publikation

FachzeitschriftBiological Chemistry
Jahrgang / Bandnr. / VolumeAhead of Print
StatusVeröffentlicht
Veröffentlichungsjahr2023
Sprache, in der die Publikation verfasst istEnglisch
DOI10.1515/hsz-2022-0216
Link zum Volltexthttps://api.elsevier.com/content/abstract/scopus_id/85146234171
StichwörterNMDAR; neurology; human stem cells; glutamatergic neurons; pharmacology; GluN2B

Autor*innen der Universität Münster

Budde, Thomas
Institut für Physiologie I